Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Nurturing Research in Pathology Northeast Pathology Chairs Meeting October, 2010
2. Beyond IHC: Quantitative measurement of protein analytes on FFPE tissue slides Attikon Hospital Seminar Series July, 2010
3. New Technologies and Potential Impact on Cytopathology 22st Annual Harvard Advances in Cytopathology CME Course June, 2010
4. Companion Diagnostics; The Pathologist as the Prescibing Physcian Scripps Clinic Pathology Seminar May, 2010
5. McArdle Labs Cancer Seminar Series April, 2010
6. Beyond IHC: Quantitative multiplexed protein analysis as a companion diagnostic tool for personalized medicine. Yale University Dept of Pathology Grand Rounds February, 2010
7. Alternative Localization and Function of Met YCC Signal Transduction Seminar Series January, 2010
8. Standardization and Validation in Measurement of Protein in Tissue NIH Biospecimens Interest Group January, 2010
9. Quantitative measurement of protein analytes on FFPE tissue slides Cell Signaling Technologies Inc. Seminar Series January, 2010
10. New Technologies relating to Circulating Tumor Cells American Society of Cytopathology Annual Meeting November, 2009
11. Beyond IHC: Quantitative measurement of protein analytes on tissue slides AACR-NCI Targeted Therapy Meeting November, 2009
12. Beyond IHC: Accurate, reproducible and quantitative measurement of protein analyte concentrations in fixed tissue Dept of Pathology Seminar November, 2009
13. Beyond IHC: Accurate, reproducible and quantitative measurement of protein analyte concentrations in fixed tissue EORTC-NCI-ASCO meeting October, 2009
14. Beyond IHC: Accurate, reproducible and quantitative measurement of protein analyte concentrations in fixed tissue PathVisions Conference September, 2009
15. Beyond IHC: Accurate, reproducible and quantitative measurement of protein analyte concentrations in fixed tissue. CAP Futurescape Conference June, 2009
16. A Systems-based Approach to Prognostic and Predictive Biomarker Studies Using Quantitative Analysis of Protein Expression: Assessment of the mTOR Pathway in NCSLC CALGB Translational Science Symposium June, 2009
17. New Technologies and Potential Impact on Cytopathology: Proteomics, Spectral Imaging & Circulating Tumor Cells 21st Annual Harvard Advances in Cytopathology CME Course June, 2009
18. Brussels Belguim Measuring Protein on Formalin Fixed, Paraffin Embedded Tissue Slides preIMPAKT Seminar May, 2009
19. Brussels Belguim Systems Pathology: Multiplexed Assessment of Protein Expression in Tissue Biopsies IMPAKT Invited Platform May, 2009
20. The Yale Cancer Center John Murren Memorial Lectureship Protein Expression Models in Lung Cancer April, 2009
21. Intrinsic Controls of FFPE tissue Biospecimen Resource Network Invited Speaker March, 2009
22. Quantitative measurement of Estrogen Receptor Expert Presentation to ASCO/CAP Panel for Standardization of Estrogen and Progesterone Receptor Analysis. December, 2008
23. A scientific examination of IHC and the ASCO/CAP guidelines for HER2 (and other issues related to assessment of protein expression on histologic sections). Wagih Bari Lectureship, Missouri Assn of Pathologists September, 2008
24. Accurate, reproducible, and quantitative measurement of protein analyte concentration(s) in tissue slides. Educational session of AACR Third International Conference on Molecular Diagnostics in Cancer Therapeutic Development September, 2008
25. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Lauren Ackerman Lecturer, Washington University Dept of Pathology September, 2008
26. Moving Molecular Prognostic tests to the Clinic; A case study of Oncotype Dx in breast cancer. SPORE conference on Melanoma July, 2008
27. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Thomas Jefferson University Medical Center, Cancer Center Grand Rounds May, 2008
28. Quantitative Assessment of Protein Expression in Paraffin: Are your pathology archives a wax museum or an oil well? AACR National Meeting Education Symposium April, 2008
29. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays University of Connecticut Cancer Biology Seminar series April, 2008
30. Examination of the ASCO/CAP guidelines for HER2; Does CALGB 9840 provide evidence for the guidelines or for change Breast Ca Committee March, 2008
31. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays University of Kentucky Cancer Center Seminar series March, 2008
32. Multiparameter Tissue Imaging to Identify cell subsets in human tissue NCI sponsored Stem Cell Conference January, 2008
33. Quantitative Assessment of Tissue Biomarkers to Predict Metastasis in Melanoma DuPont Guerry Symposium January, 2008
34. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Vanderbilt Cancer Center Seminar series October, 2007
35. Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Cancer Center Grand Rounds September, 2007
36. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Phenopath Quarterly Pathology/Immunohistochemistry Conference August, 2007
37. Beyond Brown; Immunohistochemistry in the Future Phenopath Educational Program August, 2007
38. Nuclear Met and Implications of Spatial Information in Companion Diagnostics AVEO Pharmaceuticals Seminar August, 2007
39. Multiplexed in situ Analysis of Protein expression (AQUA®) to Predict Breast Cancer Prognosis and Response to Trastuzumab 15th SPORE Investigator’s Workshop July, 2007
40. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Baylor Breast Center June, 2007
41. Quantitative imaging for companion diagnostics Scientific Advisory Board of Merrimack Pharmaceuticals May, 2007
42. Imaging Solutions for Problems in Anatomic Pathology Visiting Professor Seminar April, 2007
43. Nuclear Localization and Function of Met, the HGF Receptor Institute for Cancer Research and Treatment. Seminar series April, 2007
44. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Moffit Cancer Center Grand Rounds March, 2007
45. Thyroid FNA, Morphology and Beyond (CME). American Society of Cytopathology Meeting November, 2006
46. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays. Mayo Clinic Cancer Center Seminar Series November, 2006
47. Quantitative Analysis of Cancer Markers in Tissue Lilly Innovations Meeting October, 2006
48. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays. UCSF Cancer Center Seminar Series October, 2006
49. Quantitative Biomarkers for Companions Diagnostics RTOG annual meeting June, 2006
50. Proteomics and Digital Cytopathology 18th Annual Advances in Cytopathology CME Course June, 2006
51. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays NCI DCTD Special Lecture May, 2006
52. Biomarker Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays Lilly Pharmaceutical Discovery Seminar Series March, 2006
53. Quantitative Multiplexed Analysis of TMAs to discover Prognostic Factors for Melanoma Yale Dermatology Departmental Seminar Series January, 2006
54. Quantitative Multiplexed Analysis of TMAs to discover Prognostic Factors for Melanoma Keystone Conference on Melanoma January, 2006
55. Thyroid FNA, Morphology and Beyond Invited Expert Tutorial at the American Society of Cytopathology Meeting November, 2005
56. Quantitative Multiplexed Analysis of TMAs to Discover Prognostic Factors in Melanoma NCI sponsored meeting on tissue microarrays in melanoma October, 2005
57. Discovery by Quantitative and Multiplexed Analysis of Tissue Microarrays University of Michigan Comprehensive Cancer Center Grand Rounds October, 2005
58. Tissue Microarrays in Breast Cancer at Breast Cancer Summit, Moleuclar and Genetic Markers in Breast Cancer: Clinical Applications . Cleveland Clinic Sponsored CME course October, 2005
59. Quantitative Multiplexed Analysis of TMAs to Discover Prognostic Factors in Melanoma MD Anderson Cancer Center Melanoma Research Group Seminar August, 2005
60. Quantitative Analysis of Tissue Microarrays in Breast Cancer MD Anderson Cancer Center Women’s Cancer Research Group Seminar August, 2005
61. Proteomics and Digital Cytopathology 7th Annual Advances in Cytopathology CME Course June, 2005
62. Quantitative Analysis of Tissue Microarrays CHI Microarrays in Medicine Meeting May, 2005
63. International Society of Cellular Oncology Meeting April, 2005
64. Quantitative and Multiplexed Digital Analysis of Breast Cancer Tissue Southwest Oncology Group (SWOG) Spring Meeting April, 2005
65. Trends in Experimental Pathology, New Technologies in Investigative Pathology ASIP meeting at FASEB April, 2005
66. Career Pathways in Pathology for Clinician Scientists ASIP at FASEB meeting April, 2005
67. Quantitative Digital Analysis of Tissue Microarrays Brown Univ. and Rhode Island Hospital COBRE Center Seminar series March, 2005
68. . Growth Factor Receptors, Tissue Microarrays and Digital Pathology UNMC Eppley Cancer Center Grand Rounds March, 2005
69. Quantitative Digital Analysis of Tissue Microarrays. Mass General Hospital Dept of Pathology Grand Rounds February, 2005
70. Quantitative Digital Analysis of Tissue Microarrays Baylor Breast Cancer Center Seminar February, 2005
71. Growth Factor Receptors, Tissue Microarrays and Digital Pathology Univ of Kentucky Cancer Center Grand Rounds January, 2005
72. Functional Correlates of Exon 3 Mutations in Beta-catenin Cadherins, Catenins and Cancer. CNIO Madrid Spain December, 2004
73. New Molecular Markers in Breast Cancer Imidex Perspectives in Breast Cancer Meeting October, 2004
74. Quantitative Fluorescence-Based Analysis of Protein Expression on Tissue Microarrays Chips to Hits Meeting September, 2004
75. Quantitative Digital Analysis of Tissue Microarrays 12th SPORE Investigators Workshop July, 2004
76. Quantitative Pathology: Spectral and Digital Analysis of Tissue Microarrays and Cytology Specimens Baystate Hospital Dept of Pathology Grand Rounds June, 2004
77. Quantitative Digital Analysis of Tissue Microarrays CHI Tissue Microarray Meeting, Boston Session April, 2004
78. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Huntsman Cancer Inst. , Univ. of Utah. Seminar April, 2004
79. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Curagen Inc. Seminar Speaker March, 2004
80. Quantitative Pathology: Spectral and Digital Analysis of Tissue Microarrays and Cytology Specimens U Mass Pathology Grand Rounds February, 2004
81. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology University College London Medical Grand Rounds January, 2004
82. Quantitative Pathology: Spectral and Digital Analysis of Tissue Microarrays and Cytology Specimens UCLA Pathology Grand Rounds January, 2004
83. Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Amgen Inc. Cancer Research Group Seminar January, 2004
84. Quantitative Analysis of Tissue Microarrays Pathology Society of Great Britain and Ireland Conference, Closed Meeting at the Royal College of Pathology January, 2004
85. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Yale Cancer Center Grand Rounds December, 2003
86. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology UCONN Cancer Center Seminar November, 2003
87. New Technologies Luncheon Seminar II. American Society of Cytopathology Scientific Session November, 2003
88. Quantitative Analysis of Tissue Microarrays CNIO Tissue Microarray Meeting October, 2003
89. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Vanderbilt Digestive Disease Research Seminar September, 2003
90. Quantitative Tissue Microarray-Based Analysis of RTK expression patterns FASEB Summer Research Conf, Invited speaker August, 2003
91. Canada Tissue Microarray Construction Strategies CALGB Pathology Subgroup Featured Speaker July, 2003
92. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Brigham and Women’s Hospital Pathology Grand Rounds June, 2003
93. Cell Biology to Tissue Microarrays: Met and Beta-Catenin in Cancer Cell Contact Gordon Research Conference, Invited Speaker June, 2003
94. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Beth Israel Dept of Pathology Seminar May, 2003
95. Quantitative Analysis of Tissue Microarrays Northwestern Univ Med Image Analysis Workshop, Keynote Speaker April, 2003
96. Tissue Microarrays, Digital Pathology and Personalized Medicine Pfizer Pharmaceuticals - Discovery Group Seminar January, 2003
97. Growth Factor Receptors, Catenins, Tissue Microarrays and Digital Pathology Johns Hopkins Dept of Pathology Grand Rounds January, 2003
98. Tissue Microarrays, Digital Pathology and Personalized Medicine Genentech Pathology Dept. Seminar December, 2002
99. New Applications in Diagnostic Cytopathology NY Pathology Society Lecture November, 2002
100. Tissue Microarrays, Digital Pathology and Personalized Medicine University of Pittsburgh. Totten Lecture November, 2002
101. Molecular Cytogenetic Analysis of Breast Duct Lavage Specimens is More Sensitive Than Morphologic Evaluation American Society of Cytopathology Scientific Session November, 2002
102. New Technologies Luncheon Seminar. American Society of Cytopathology Scientific Session November, 2002
103. Colorectal Cancer Tissue Microarrays and Digital Pathology 1st International Colo-rectal Cancer Congress November, 2002
104. Introduction to Breast Duct Lavage Northeast Regional Cytopathology Conference October, 2002
105. Beta-catenin Mediated Signaling: Analysis by Cell Biology and Tissue Microarray Montefiore Hospital Pathology Grand Rounds September, 2002
106. Automated Analysis of Tissue Microarrays, An update Tissue Microarray Workshop Faculty AIMCL ’02 May, 2002
107. Cytology Diagnostic Seminar United States and Canadian Academy of Pathology Annual Scientific Meeting February, 2002
108. Beta-catenin Mediated Signaling: Analysis by Cell Biology and Tissue Microarray NYU Cancer Center Seminar February, 2002
109. Diagnostic Slide Seminar Panelist American Society of Cytopathology Scientific Session November, 2001
110. Automated Analysis of Tissue Microarrays Tissue Microarray Workshop Faculty AIMCL ’01 May, 2001
111. ASCUS; who needs it American Society of Cytopathology Scientific Session November, 2000
112. PCR based Billable Diagnostic tests Current Concepts Symposium: American Society of Cytopathology Scientific Session November, 2000
113. Cell Adhesion and Cancer Cell Signaling Technologies, Inc., scientific seminar October, 2000
114. Cell Adhesion and Cancer University of Vermont, Pathology Grand Rounds May, 2000
115. Adhesion and Cancer University of Virginia, Pathology Seminar Series March, 2000
116. ASCUS in women over 50 Years Old American Society of Cytopathology Scientific Session November, 1999
117. Cell Adhesion and Cancer University of Toledo, Biology Dept. Seminar Series September, 1999
118. Future Directions in the Diagnosis of Cancer University of Toledo Presidential Inaugural Symposium September, 1999
119. Cell Adhesion and Cancer Ariad Pharmaceutical Genome Institute Seminar June, 1999
120. Cell Adhesion and Cancer Northwestern University Pathology Seminar Series May, 1999
121. Cell Adhesion and Cancer Case Western Reserve U. Microbiology Seminar series March, 1999
122. Cell Adhesion and Cancer University of Iowa Pathology Grand Rounds January, 1999
123. Cell Adhesion and Cancer Baystate Hospital Pathology Grand Rounds January, 1998
124. PCR-based assessment of clonality in Breast Cancer Platform presentation: American Society of Cytopathology Scientific Session November, 1997
125. The Role of Met in Breast Cancer Platform Presentation Era Of Hope Army sponsored Breast Cancer Meeting October, 1997
126. Cadherins and Cancer Lankanau Medical Center Seminar Series January, 1997
127. Cadherins in Disease Case Western Reserve, Graduate Molecular Biology Course March, 1996
128. Cell Adhesion and Cancer Georgetown Cell Biology Seminar Series January, 1996
129. Cost savings as a result of FNA American Society of Cytopathology Scientific Session November, 1995
130. Alpha-catenin binds actin American Society for Cell Biology December, 1994
131. Atypical Reparative Change Platform presentation: American Society of Cytopathology Scientific Session November, 1994



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Quantitative methods to assess eligibility for breast cancer therapy 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium December, 2010

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.